BlackRock Health Sciences Trust II (BMEZ) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BlackRock Health Sciences Trust II (BMEZ) has a cash flow conversion efficiency ratio of 0.103x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($78.91 Million) by net assets ($768.57 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is BlackRock Health Sciences Trust II's balance sheet to measure how much of total assets are equity-financed.
BlackRock Health Sciences Trust II - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how BlackRock Health Sciences Trust II's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check BlackRock Health Sciences Trust II earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
BlackRock Health Sciences Trust II Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BlackRock Health Sciences Trust II ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aebi Schmidt Holding AG - Common Stock
NASDAQ:AEBI
|
-0.022x |
|
Suqian Unitech Corp. Ltd. Cl A
SHG:603065
|
N/A |
|
Criteo Sa
NASDAQ:CRTO
|
0.136x |
|
EcoRodovias Infraestrutura e Logística S.A
SA:ECOR3
|
0.312x |
|
Poly Plastic Masterbatch Suzhou Co
SHE:300905
|
0.031x |
|
United Renewable Energy Co Ltd
TW:3576
|
-0.011x |
|
Vor Biopharma Inc
NASDAQ:VOR
|
0.254x |
|
Piraeus Port Authority S.A
AT:PPA
|
0.158x |
Annual Cash Flow Conversion Efficiency for BlackRock Health Sciences Trust II (2019–2024)
The table below shows the annual cash flow conversion efficiency of BlackRock Health Sciences Trust II from 2019 to 2024. For the full company profile with market capitalisation and key ratios, see BlackRock Health Sciences Trust II (BMEZ) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $768.57 Million | $65.52 Million | 0.085x | +56.59% |
| 2023-12-31 | $588.14 Million | $32.02 Million | 0.054x | +3838.40% |
| 2022-12-31 | $600.20 Million | $-874.04K | -0.001x | +95.77% |
| 2021-12-31 | $625.77 Million | $-21.56 Million | -0.034x | -117.55% |
| 2020-12-31 | $545.94 Million | $107.17 Million | 0.196x | +121.20% |
| 2019-12-31 | $1.64 Billion | $-1.52 Billion | -0.926x | -- |
About BlackRock Health Sciences Trust II
BlackRock Health Sciences Trust II operates in various business sectors.